562 related articles for article (PubMed ID: 29898899)
1. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.
Fan J; Lee HO; Lee S; Ryu DE; Lee S; Xue C; Kim SJ; Kim K; Barkas N; Park PJ; Park WY; Kharchenko PV
Genome Res; 2018 Aug; 28(8):1217-1227. PubMed ID: 29898899
[TBL] [Abstract][Full Text] [Related]
2. Deciphering intratumor heterogeneity using cancer genome analysis.
Ryu D; Joung JG; Kim NK; Kim KT; Park WY
Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
[TBL] [Abstract][Full Text] [Related]
3. Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.
Parisi F; Ariyan S; Narayan D; Bacchiocchi A; Hoyt K; Cheng E; Xu F; Li P; Halaban R; Kluger Y
BMC Genomics; 2011 May; 12():230. PubMed ID: 21569352
[TBL] [Abstract][Full Text] [Related]
4. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
Yu Z; Li A; Wang M
BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
[TBL] [Abstract][Full Text] [Related]
5. Haplotype-aware analysis of somatic copy number variations from single-cell transcriptomes.
Gao T; Soldatov R; Sarkar H; Kurkiewicz A; Biederstedt E; Loh PR; Kharchenko PV
Nat Biotechnol; 2023 Mar; 41(3):417-426. PubMed ID: 36163550
[TBL] [Abstract][Full Text] [Related]
6. Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.
Donmez N; Malikic S; Wyatt AW; Gleave ME; Collins CC; Sahinalp SC
J Comput Biol; 2017 Jun; 24(6):515-523. PubMed ID: 28056180
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA-seq variant analysis for exploration of genetic heterogeneity in cancer.
Fasterius E; Uhlén M; Al-Khalili Szigyarto C
Sci Rep; 2019 Jul; 9(1):9524. PubMed ID: 31267007
[TBL] [Abstract][Full Text] [Related]
8. CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.
Yu Z; Li A; Wang M
BMC Bioinformatics; 2016 Aug; 17():310. PubMed ID: 27538789
[TBL] [Abstract][Full Text] [Related]
9. Principles of Reconstructing the Subclonal Architecture of Cancers.
Dentro SC; Wedge DC; Van Loo P
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28270531
[TBL] [Abstract][Full Text] [Related]
10. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Lohr JG; Stojanov P; Carter SL; Cruz-Gordillo P; Lawrence MS; Auclair D; Sougnez C; Knoechel B; Gould J; Saksena G; Cibulskis K; McKenna A; Chapman MA; Straussman R; Levy J; Perkins LM; Keats JJ; Schumacher SE; Rosenberg M; ; Getz G; Golub TR
Cancer Cell; 2014 Jan; 25(1):91-101. PubMed ID: 24434212
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Transcriptomic Analysis of Tumor Heterogeneity.
Levitin HM; Yuan J; Sims PA
Trends Cancer; 2018 Apr; 4(4):264-268. PubMed ID: 29606308
[TBL] [Abstract][Full Text] [Related]
12. Single-cell epigenomic variability reveals functional cancer heterogeneity.
Litzenburger UM; Buenrostro JD; Wu B; Shen Y; Sheffield NC; Kathiria A; Greenleaf WJ; Chang HY
Genome Biol; 2017 Jan; 18(1):15. PubMed ID: 28118844
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.
Croucher DC; Richards LM; Tsofack SP; Waller D; Li Z; Wei EN; Huang XF; Chesi M; Bergsagel PL; Sebag M; Pugh TJ; Trudel S
Nat Commun; 2021 Nov; 12(1):6322. PubMed ID: 34732728
[TBL] [Abstract][Full Text] [Related]
14. Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors.
Mitra AK; Mukherjee UK; Harding T; Jang JS; Stessman H; Li Y; Abyzov A; Jen J; Kumar S; Rajkumar V; Van Ness B
Leukemia; 2016 May; 30(5):1094-102. PubMed ID: 26710886
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
[TBL] [Abstract][Full Text] [Related]
16. TargetClone: A multi-sample approach for reconstructing subclonal evolution of tumors.
Nieboer MM; Dorssers LCJ; Straver R; Looijenga LHJ; de Ridder J
PLoS One; 2018; 13(11):e0208002. PubMed ID: 30496231
[TBL] [Abstract][Full Text] [Related]
17. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.
Fan Y; Xi L; Hughes DS; Zhang J; Zhang J; Futreal PA; Wheeler DA; Wang W
Genome Biol; 2016 Aug; 17(1):178. PubMed ID: 27557938
[TBL] [Abstract][Full Text] [Related]
18. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
Dentro SC; Leshchiner I; Haase K; Tarabichi M; Wintersinger J; Deshwar AG; Yu K; Rubanova Y; Macintyre G; Demeulemeester J; Vázquez-García I; Kleinheinz K; Livitz DG; Malikic S; Donmez N; Sengupta S; Anur P; Jolly C; Cmero M; Rosebrock D; Schumacher SE; Fan Y; Fittall M; Drews RM; Yao X; Watkins TBK; Lee J; Schlesner M; Zhu H; Adams DJ; McGranahan N; Swanton C; Getz G; Boutros PC; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Martincorena I; Markowetz F; Mustonen V; Yuan K; Gerstung M; Spellman PT; Wang W; Morris QD; Wedge DC; Van Loo P;
Cell; 2021 Apr; 184(8):2239-2254.e39. PubMed ID: 33831375
[TBL] [Abstract][Full Text] [Related]
19. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
Shen R; Seshan VE
Nucleic Acids Res; 2016 Sep; 44(16):e131. PubMed ID: 27270079
[TBL] [Abstract][Full Text] [Related]
20. Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies.
González-Silva L; Quevedo L; Varela I
Trends Cancer; 2020 Jan; 6(1):13-19. PubMed ID: 31952776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
